基于基因网络和基于组合建模的瘤相关抗原的选择,预计针对向免疫疗法的组织损伤风险较低
Christopher Lischer1,2, Martin Eberhardt1,2, Cindy Flamann3,4
1Hautklinik, Universitätsklinikum Erlangen, Erlangen, Germany.
Journal for immunotherapy of cancer
|May 9, 2024
概括
这项研究引入了一个计算管道,用于为癌症免疫治疗选择瘤抗原. 该方法优先考虑激发抗瘤免疫力的抗原,同时尽量减少组织损伤,为新型癌症治疗铺平了道路.
科学领域:
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 与瘤相关的抗原为开发广泛适用的癌症免疫疗法提供了一个有希望的途径.
- 一个强大的抗原选择过程对于推进免疫疗法试验至关重要,特别是对于罕见的癌症.
研究的目的:
- 开发和验证用于免疫治疗选择瘤抗原的计算管道.
- 为了识别引起抗瘤免疫反应的抗原,具有较低的不良事件风险.
主要方法:
- 一个数据驱动的计算管道,集成抗原表达特征,不可或缺的网络分析和用于免疫性预测的机器学习.
- 通过评估瘤和健康组织中的抗原表达来最大限度地减少与免疫相关的不良事件.
- 使用人类白细胞抗原 (HLA) 对接模拟和对-MHC结合亲缘关系的实验验证.
主要成果:
- 该管道准确地区分高和低亲和度,与现有方法相比.
- 实验证实了T细胞刺激和细胞毒性活性,尽管有捐赠者之间的变异性.
- 管道成功排除了具有细胞毒性潜力的,但具有组织损伤或不稳定表达风险的.
结论:
- 证明了 de novo计算抗原选择的可行性,以获得低预测组织损伤的抗瘤免疫力.
- 该管道支持临床转换的快速验证,包括采用T细胞转移.
- 能够实现通用和个性化的抗原导向免疫疗法策略.
相关概念视频
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


